News
CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission ...
A global study on the neurological effects of the COVID-19 vaccine reveals key trends, with the U.S. leading in publications ...
The analysis found that chemotherapy and prior thrombotic events increase the risk for COVID-related hospitalization, while ...
According to the research, 82% of the lives saved involved individuals who had received the vaccine before being infected by ...
Moderna has received marketing authorisation from the European Commission for its updated COVID-19 vaccine, Spikevax, which ...
2h
Good Good Good on MSNScientists say dental floss vaccines could be the future of flu and COVID shotsIn lab mice trials, researchers found the vaccine delivery method to provide a “far superior” antibody response compared to ...
Texas medical freedom advocates have been pushing against vaccine requirements and recommendations for years. Now, they're in ...
Moderna’s LP.8.1-adapted COVID-19 vaccine has been recommended by the European Medicines Agency (EMA)’s human medicines ...
Your premium access has ended, but the best of Nation.Africa is still within reach. Renew now to unlock exclusive stories and ...
1d
Medindia on MSNCOVID-19 and Vaccination Linked to Neurological ProblemsCOVID-19 can trigger serious brain and nerve problems, including stroke, seizures, and memory loss, even weeks after recovery ...
CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission ...
The COVID-19 pandemic upended life for individuals and communities worldwide. Social isolation, health mandates, illness, and economic hardships took a toll on the well-being of families and children, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results